Abbott Laboratories - 35 Year Stock Price History | ABT
Historical daily share price chart and data for Abbott Laboratories since 1983 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Abbott Laboratories as of November 13, 2018 is 69.49.
| Abbott Laboratories Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2018 | 63.0724 | 57.9762 | 74.1200 | 55.7546 | 69.4900 | 23.47% |
| 2017 | 47.4997 | 37.6421 | 56.6744 | 37.6421 | 56.2800 | 52.00% |
| 2016 | 38.6495 | 40.3639 | 43.3818 | 34.3884 | 37.0251 | -12.32% |
| 2015 | 43.1634 | 41.3317 | 47.8589 | 36.5111 | 42.2255 | 1.89% |
| 2014 | 37.3928 | 34.4215 | 42.6848 | 32.4602 | 41.4421 | 20.08% |
| 2013 | 31.9015 | 28.3980 | 34.8537 | 28.3980 | 34.5116 | 23.75% |
| 2012 | 26.5688 | 23.7775 | 30.7100 | 22.7945 | 27.8872 | 18.31% |
| 2011 | 21.2605 | 19.6943 | 23.6140 | 18.6813 | 23.5721 | 19.46% |
| 2010 | 20.7542 | 22.0757 | 22.8763 | 18.7295 | 19.7314 | -9.84% |
| 2009 | 19.5067 | 21.3712 | 22.9224 | 16.6961 | 21.8851 | 2.77% |
| 2008 | 21.8949 | 21.9949 | 23.9047 | 19.7313 | 21.2954 | -3.77% |
| 2007 | 21.3497 | 19.0808 | 23.2851 | 19.0808 | 22.1289 | 16.59% |
| 2006 | 17.4602 | 15.2139 | 19.2210 | 15.2139 | 18.9795 | 25.13% |
| 2005 | 17.3683 | 17.7512 | 19.1169 | 14.4753 | 15.1677 | -14.52% |
| 2004 | 15.6873 | 16.4456 | 17.8729 | 13.8767 | 17.7436 | 8.24% |
| 2003 | 14.4605 | 13.9401 | 16.5863 | 11.9986 | 16.3928 | 17.74% |
| 2002 | 15.8908 | 19.2507 | 19.9255 | 10.7619 | 13.9227 | -27.56% |
| 2001 | 17.2106 | 16.4658 | 19.5713 | 14.4180 | 19.2196 | 15.98% |
| 2000 | 14.2275 | 11.8783 | 19.0726 | 10.0783 | 16.5718 | 34.48% |
| 1999 | 14.7626 | 16.4351 | 17.8985 | 11.3047 | 12.3229 | -25.40% |
| 1998 | 13.7622 | 11.3133 | 16.7722 | 11.1875 | 16.5194 | 50.34% |
| 1997 | 10.3218 | 8.4085 | 11.5130 | 8.4085 | 10.9879 | 29.72% |
| 1996 | 7.5467 | 6.9350 | 9.4717 | 6.4438 | 8.4703 | 22.49% |
| 1995 | 6.3804 | 5.3927 | 7.4045 | 5.1716 | 6.9150 | 28.23% |
| 1994 | 4.8930 | 4.7458 | 5.5580 | 4.2994 | 5.3927 | 10.75% |
| 1993 | 4.4008 | 4.9637 | 4.9637 | 3.7741 | 4.8691 | -1.91% |
| 1992 | 5.0069 | 5.4759 | 5.5468 | 4.4012 | 4.9637 | -11.49% |
| 1991 | 4.2366 | 3.5139 | 5.6078 | 3.2314 | 5.6078 | 53.39% |
| 1990 | 3.0953 | 2.8081 | 3.6967 | 2.5554 | 3.6560 | 32.59% |
| 1989 | 2.3948 | 1.9337 | 2.8438 | 1.8890 | 2.7574 | 41.47% |
| 1988 | 1.8956 | 1.9666 | 2.1035 | 1.7401 | 1.9491 | -0.11% |
| 1987 | 2.3247 | 1.9196 | 2.7034 | 1.7389 | 1.9513 | 5.82% |
| 1986 | 1.7726 | 1.3729 | 2.1961 | 1.2873 | 1.8440 | 33.58% |
| 1985 | 1.1005 | 0.8197 | 1.4160 | 0.8072 | 1.3804 | 63.88% |
| 1984 | 0.8661 | 0.9273 | 0.9682 | 0.7667 | 0.8423 | -7.66% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $123.927B | $27.390B |
| Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $125.111B | 19.18 |
| Stryker (SYK) | United States | $63.616B | 23.98 |
| Boston Scientific (BSX) | United States | $51.104B | 25.83 |
| Baxter (BAX) | United States | $32.759B | 21.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.343B | 15.14 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.929B | 0.00 |
| ResMed (RMD) | United States | $14.783B | 28.19 |
| Canopy Growth (CGC) | Canada | $9.096B | 0.00 |
| Perrigo (PRGO) | Ireland | $8.909B | 13.52 |
| Bio-Rad Laboratories (BIO) | United States | $8.086B | 51.70 |
| Aurora Cannabis (ACB) | Canada | $6.688B | 36.63 |
| Hill-Rom Holdings (HRC) | United States | $6.277B | 19.90 |
| Haemonetics (HAE) | United States | $5.440B | 47.85 |
| Insulet (PODD) | United States | $4.849B | 0.00 |
| ICU Medical (ICUI) | United States | $4.490B | 25.04 |
| Hutchison China MediTech (HCM) | China | $4.221B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.051B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.732B | 0.00 |
| Neogen (NEOG) | United States | $3.281B | 49.69 |
| National Vision Holdings (EYE) | United States | $3.207B | 70.82 |
| NuVasive (NUVA) | United States | $2.954B | 27.49 |
| Aphria (APHA) | $2.817B | 0.00 | |
| Quidel (QDEL) | United States | $2.479B | 32.31 |
| NxStage Medical (NXTM) | United States | $1.925B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.446B | 20.47 |
| AtriCure (ATRC) | United States | $1.192B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.046B | 1507.50 |
| VAREX IMAGING (VREX) | United States | $1.018B | 16.63 |
| PetIQ (PETQ) | United States | $0.849B | 27.76 |
| Meridian Bioscience (VIVO) | United States | $0.828B | 26.38 |
| OraSure Technologies (OSUR) | United States | $0.826B | 46.52 |
| Surmodics (SRDX) | United States | $0.787B | 120.33 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.753B | 24.16 |
| Cerus (CERS) | United States | $0.715B | 0.00 |
| MacroGenics (MGNX) | United States | $0.702B | 0.00 |
| Omeros (OMER) | United States | $0.628B | 0.00 |
| Owens & Minor (OMI) | United States | $0.575B | 6.50 |
| Lantheus Holdings (LNTH) | United States | $0.572B | 17.69 |
| Insys Therapeutics (INSY) | United States | $0.548B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.526B | 25.81 |
| NanoString Technologies (NSTG) | United States | $0.455B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.444B | 0.00 |
| Evolus (EOLS) | United States | $0.401B | 0.00 |
| Quanterix (QTRX) | United States | $0.362B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.325B | 20.99 |
| Cytosorbents (CTSO) | United States | $0.306B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.266B | 0.00 |
| Surface Oncology (SURF) | United States | $0.226B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.214B | 289.75 |
| Bovie Medical (BVX) | United States | $0.204B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.201B | 0.00 |
| Chimerix (CMRX) | United States | $0.162B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.156B | 0.00 |
| Fonar (FONR) | United States | $0.141B | 7.11 |
| Chembio Diagnostics (CEMI) | United States | $0.112B | 0.00 |
| Imprimis Pharmaceuticals (IMMY) | United States | $0.091B | 0.00 |
| United-Guardian (UG) | United States | $0.079B | 16.60 |
| Female Health (VERU) | United States | $0.077B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | Israel | $0.071B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.068B | 21.67 |
| InfuSystems Holdings (INFU) | United States | $0.060B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.055B | 0.00 |
| Neurotrope (NTRP) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.029B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.025B | 0.00 |
| Myomo (MYO) | United States | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.020B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.000B | 0.00 |
